Li, Y., Li, M., Shats, I., Krahn, J. M., Flake, G. P., Umbach, D. M., . . . Li, L. (2019). Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma. PLoS One.
Chicago Style CitationLi, Yuanyuan, Melissa Li, Igor Shats, Juno M. Krahn, Gordon P. Flake, David M. Umbach, Xiaoling Li, i Leping Li. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS One 2019.
Cita MLALi, Yuanyuan, et al. "Glypican 6 Is a Putative Biomarker for Metastatic Progression of Cutaneous Melanoma." PLoS One 2019.
Atenció: Aquestes cites poden no estar 100% correctes.